Reply
James Nelson, Kris Kowdley – 10 January 2011
Liver cell implants: A long road
Humphrey Hodgson, Clare Selden – 10 January 2011
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1
William Sievert, Gregory J. Dore, Geoffrey W. McCaughan, Motoko Yoshihara, Darrell H. Crawford, Wendy Cheng, Martin Weltman, William Rawlinson, Bishoy Rizkalla, Jean K. DePamphilis, Stuart K. Roberts, on behalf of the CHARIOT Study Group – 10 January 2011 – Anemia may increase the likelihood of achieving a sustained virological response (SVR) during pegylated interferon and ribavirin treatment of hepatitis C virus (HCV) infection. To determine whether hemoglobin decline is associated with SVR, we retrospectively evaluated the CHARIOT study of 871 treatment‐naïve HCV genotype 1 patients.
Is cytomegalovirus infection dangerous in cytomegalovirus‐seropositive recipients after liver transplantation?
Jong Man Kim, Sung‐Joo Kim, Jae‐Won Joh, Choon Hyuck David Kwon, Sanghyun Song, Milljae Shin, Ju Ik Moon, Gaab Soo Kim, Seung Heui Hong, Suk‐Koo Lee – 10 January 2011 – Cytomegalovirus (CMV) infections contracted after liver transplantation put patients at an increased risk of morbidity and mortality. We analyzed the effects of CMV infection by time of onset, mortality, and graft failure risk factors in liver recipients who were CMV donor‐positive/recipient‐positive (D+/R+). We reviewed 618 medical records for consecutive adult liver transplant cases.
Comment on a systematic review of randomized trials of peginterferon alpha‐2a versus peginterferon alpha‐2b in chronic hepatitis C
Ashwani K. Singal, Sarat C. Jampana, Bhupinderjit S. Anand – 10 January 2011
Inflammation does not always kill hepatocytes during liver damage
Honglei Weng, Hai Li, Steven Dooley – 10 January 2011
Reply
Lionel Piroth, Christine Larsen, Elisabeth Delarocque‐Astagneau, Stanislas Pol – 10 January 2011
Reply
Milan J. Sonneveld, Vincent Rijckborst, Harry L.A. Janssen – 10 January 2011
In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis
A.J. di Mambro, R. Parker, A. McCune, F. Gordon, C.M. Dayan, P. Collins – 10 January 2011 – Steroids improve the outcome in alcoholic hepatitis (AH), but up to 40% of patients fail to respond adequately. Interleukin‐2 (IL‐2) exacerbates steroid resistance in vitro. We performed a prospective study to determine if intrinsic steroid sensitivity correlates with response to steroids in individuals with severe AH and if IL‐2 receptor blockade can reverse this. Peripheral blood mononuclear cells (PBMCs) were isolated from 20 patients with AH and a Maddrey's score >32.
Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal
J. Ignacio Herrero, Fernando Pardo, Delia D'Avola, Félix Alegre, Fernando Rotellar, Mercedes Iñarrairaegui, Pablo Martí, Bruno Sangro, Jorge Quiroga – 10 January 2011 – Liver transplant recipients have an increased risk of malignancy. Smoking is related to some of the most frequent causes of posttransplant malignancy. The incidence and risk factors for the development of neoplasia related to smoking (head and neck, lung, esophageal, and kidney and urinary tract carcinomas) were studied in 339 liver transplant recipients.